Welcome to LookChem.com Sign In|Join Free
  • or
Alanine, N-(4-aminobenzoyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

99146-89-1

Post Buying Request

99146-89-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

99146-89-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 99146-89-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,1,4 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 99146-89:
(7*9)+(6*9)+(5*1)+(4*4)+(3*6)+(2*8)+(1*9)=181
181 % 10 = 1
So 99146-89-1 is a valid CAS Registry Number.

99146-89-1Downstream Products

99146-89-1Relevant academic research and scientific papers

Novel glucagon antagonists

-

, (2008/06/13)

Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.

2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith

-

, (2008/06/13)

The present invention provides a pharmaceutical composition for treating ulcerative colitis containing at least one compound of the general formula: STR1 wherein X is an --SO2 -- or --CO-- group and R is either an unsubstituted or substituted non-heterocyclic aromatic ring system or is a radical of the general formula --(CH2)n --Y, in which Y is a hydroxyl group, an unsubstituted or substituted amino group or a carboxylic or sulphonic acid group and n is a whole number of from 1 to 6 and in which one or more hydrogen atoms in the alkylene radical can be replaced by unsubstituted or substituted amino groups or alkyl radicals and in which the --(CH2)n --Y radical is either attached directly to the nitrogen atom or via a benzene ring; and/or containing at least one ester thereof and/or at least one non-toxic, pharmaceutically acceptable salt thereof, in admixture with a solid or liquid pharmaceutical diluent or carrier. Furthermore, the present invention provides a process for preparing the compounds of the above-given general formulae and also provides a method of treating ulcerative colitis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 99146-89-1